Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.
2.

Cannabinoids and intestinal motility: welcome to CB2 receptors.

Izzo AA.

Br J Pharmacol. 2004 Aug;142(8):1201-2. Review.

3.
4.

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.

Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M.

Prog Lipid Res. 2013 Oct;52(4):633-50. doi: 10.1016/j.plipres.2013.05.004. Review.

PMID:
24076098
5.

International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA.

Pharmacol Rev. 2010 Dec;62(4):588-631. doi: 10.1124/pr.110.003004. Review.

6.

Prospects for cannabinoid therapies in basal ganglia disorders.

Fernández-Ruiz J, Moreno-Martet M, Rodríguez-Cueto C, Palomo-Garo C, Gómez-Cañas M, Valdeolivas S, Guaza C, Romero J, Guzmán M, Mechoulam R, Ramos JA.

Br J Pharmacol. 2011 Aug;163(7):1365-78. doi: 10.1111/j.1476-5381.2011.01365.x. Review.

7.

The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.

Miller LK, Devi LA.

Pharmacol Rev. 2011 Sep;63(3):461-70. doi: 10.1124/pr.110.003491. Review.

8.

[Research progress of role of cannabinoid receptor in fibrosis].

Li S, Wang L, Liu M, Gao Y, Tian Z, Jiang S, Zhang M, Guan D.

Zhonghua Bing Li Xue Za Zhi. 2014 Feb;43(2):136-8. Review. Chinese. No abstract available.

PMID:
24742582
9.

Mode of action of cannabinoids on nociceptive nerve endings.

Kress M, Kuner R.

Exp Brain Res. 2009 Jun;196(1):79-88. doi: 10.1007/s00221-009-1762-0. Review.

PMID:
19306092
10.

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.

McAllister SD, Soroceanu L, Desprez PY.

J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Review.

11.

The role of CB1 in immune modulation by cannabinoids.

Kaplan BL.

Pharmacol Ther. 2013 Mar;137(3):365-74. doi: 10.1016/j.pharmthera.2012.12.004. Review.

PMID:
23261520
12.

Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA.

Drug Alcohol Depend. 2014 Nov 1;144:12-41. doi: 10.1016/j.drugalcdep.2014.08.005. Review.

13.

Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Smith TH, Sim-Selley LJ, Selley DE.

Br J Pharmacol. 2010 Jun;160(3):454-66. doi: 10.1111/j.1476-5381.2010.00777.x. Review.

14.

Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas.

Stella N.

Glia. 2010 Jul;58(9):1017-30. doi: 10.1002/glia.20983. Review.

15.

Signal transduction via cannabinoid receptors.

Dalton GD, Bass CE, Van Horn CG, Howlett AC.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):422-31. Review.

16.

Efficacy in CB1 receptor-mediated signal transduction.

Howlett AC.

Br J Pharmacol. 2004 Aug;142(8):1209-18. Review.

17.

CB(1) cannabinoid receptors and their associated proteins.

Howlett AC, Blume LC, Dalton GD.

Curr Med Chem. 2010;17(14):1382-93. Review.

18.

Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression.

Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P.

Immunobiology. 2010 Aug;215(8):598-605. doi: 10.1016/j.imbio.2009.04.001. Review.

19.

Understanding functional residues of the cannabinoid CB1.

Shim JY.

Curr Top Med Chem. 2010;10(8):779-98. Review.

20.

The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.

Stadel R, Ahn KH, Kendall DA.

J Neurochem. 2011 Apr;117(1):1-18. doi: 10.1111/j.1471-4159.2011.07186.x. Review.

Items per page

Supplemental Content

Support Center